Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy versus R0 Resection for Resectable Colorectal Cancer with Peritoneal Metastases with Low Peritoneal Cancer Index Score: A Collaborative Observational Study from Korea and Japan

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy versus R0 Resection for Resectable Colorectal Cancer with Peritoneal Metastases with Low Peritoneal Cancer Index Score: A Collaborative Observational Study from Korea and Japan - CRS + HIPEC vs R0 resection alone

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051539

Enrollment

166

Registered

2023-07-06

Start date

2022-12-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer with Peritoneal Metastases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a PCI score of 6 or less and CC-0, who underwent surgery between July 2014 and December 2021 for both synchronous and metachronous CPM, were included in this study.

Exclusion criteria

Exclusion criteria: Patients with appendiceal cancer were excluded.

Design outcomes

Primary

Measure	Time frame
Relapse-free survival (RFS), which was defined as the time from surgery for CPM to the first peritoneal or distant relapse or death from any cause.	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactDaichi Kitaguchi

National Cancer Center Hospital East Department of Colorectal Surgery

dkitaguc@east.ncc.go.jp+81-4-7133-1111

Outcome results